Jafron Biomedical Co.,Ltd. (300529.SZ) SHZ

20.15

+0.26(+1.31%)

Updated at December 05 03:04PM

Currency In CNY

Valuation

Market Cap22.92B
Enterprise Value22.39B
P/E Ratio31.92
PEG Ratio-1.2
Price/Sales Ratio7.47
Price/Book Ratio4.48
Enterprise/Revenue7.96
Enterprise/EBITDA22.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.24
Operating Margin0.32

Management Effectiveness

Return On Assets0.09
Return On Equity0.14

Income Statement

Revenue2.68B
Revenue/Share2.66
Gross Profit2.16B
EBITDA1.12B
Net Income820.2M
Diluted EPS1.05

Balance Sheet

Total Cash2.49B
Total Cash/Share3.25
Total Debt1.46B
Total Debt/Equity0.43
Current Ratio4.26
Book Value Per Share4.48

Price History

52-Week Change-31.98
52-Week High31.49
52-Week Low19.66
Moving Average 50 Days21.11
Moving Average 200 Days22.72

Statistics

Average Volume5.55M
Shares Outstanding757.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield3.98
Payout Ratio1.34
Last Split Factor19:10
Last Split DateMay 20, 2020